Xenon Pharmaceuticals XENE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$102.3M-57.3% | -$105.26M-60.3% | -$90.9M-44.8% | -$84.71M-46.2% | -$65.05M-35.7% | ||
| $587K-10.9% | $611K-8.3% | $641K-3.9% | $632K-1.4% | $659K+12.5% | ||
| $16.89M+38.8% | $14.12M+3.8% | $13.71M+5.4% | $13.71M-6.8% | $12.17M+29.5% | ||
| -$88.9M-44.2% | -$81.48M-49.8% | -$71.75M-44.5% | -$64.23M-106% | -$61.65M-33.5% | ||
| $133K+209% | $318K-59.4% | $281K-52.4% | $157K-89.6% | $43K-77.1% | ||
| -$407.28M-1,280% | $62.7M-36.4% | $38.53M+7,637% | $82.26M-24.7% | $34.51M+180% | ||
| $843.01M+73,142% | $113.54M+836% | $2.36M— | $65K— | $1.15M— | ||
| $346.7M+1,431% | $94.65M— | -$30.87M+37.2% | $18.72M— | -$26.06M+71.0% | ||
| -$89.03M-44.3% | -$81.8M-48.3% | -$72.03M-43.3% | -$64.39M-97.1% | -$61.7M-33.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Xenon Pharmaceuticals generate?
- Xenon Pharmaceuticals (XENE) generated -$306.4M in operating cash flow over the trailing twelve months.
- What is Xenon Pharmaceuticals's free cash flow?
- After $889.0K of capital expenditures, Xenon Pharmaceuticals's free cash flow was -$307.3M over the trailing twelve months, down 53.8% year over year.
- Where does Xenon Pharmaceuticals's cash flow data come from?
- Every line is extracted from Xenon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.